The absence of pCR following neoadjuvant chemotherapy showed a trend toward increased progression risk (HR = 2.15, 95% CI: 0.83–5.55), but this did not reach statistical significance ( p = 0.113).
← all excerpts
Prognostic Value of the Prognostic Nutritional Index in Patients with Locally Advanced Bladder Cancer Receiving Perioperative Chemotherapy: A Multicenter Real-World Study.
1
—
—